KORE Connected Health -

The opioid epidemic continues to present significant challenges to public health, with nearly 87,000 drug overdose fatalities recorded in 2024. And while this marks a decline from previous years, some states remain harder hit than others. West Virginia continues to face substantial challenges related to the opioid crisis. 

In response, a groundbreaking partnership between VeeOne Health, Social Mobile, and KORE has been instrumental in supporting drug control policy in West Virginia. Together, these organizations have deployed an innovative solution aimed at reducing relapse rates among individuals recovering from substance use disorder (SUD).

PurpleLab -

Life sciences companies are operating in a new world, one where new treatments are being developed at breakneck speed, which holds unprecedented promise for patients. However, this new world is also one that requires the use of real world data (RWD) to empower marketing teams to effectively engage with various stakeholders – and ultimately lead healthcare providers to prescribe innovative drugs to the patients who will truly benefit from these treatment therapies.

PurpleLab -

Analyzing real-world data (RWD) in pharmaceutical marketing has the power to unearth hidden trends and insights into the overall prescription landscape. However, accessing and compiling this data tends to be a resource-intensive process. This case study explores how PurpleLab’s Prescription Measurement Report empowered the marketing agency Deerfield to harness RWD insights effectively.

ReadCube -

The pharmaceutical industry is evolving rapidly, but inefficient research workflows can slow innovation. With scientific literature growing exponentially and regulatory compliance becoming more demanding, AI is emerging as a transformative tool. 

This white paper explores how AI-driven solutions can streamline literature reviews, accelerate drug discovery, and enhance compliance, ultimately reducing time-to-market for critical breakthroughs. Learn how AI can automate tedious processes, improve data management, and provide real-time insights—allowing researchers to focus on what truly matters: advancing medicine. Dive in and discover the future of pharmaceutical research!

ReadCube -

Introducing Literature Review by ReadCube

Systematic Literature Reviews (SLRs) help researchers and organizations navigate the growing sea of academic knowledge. Yet, traditional SLRs are slow, costly, and error-prone due to fragmented workflows.

What if you could transform your SLR process?

In The Future of Systematic Literature Reviews white paper, ReadCube introduces an AI-driven solution that streamlines workflows, reducing costs and improving accuracy. Discover the challenges of traditional reviews, the role of AI and automation, and how an all-in-one platform saves time and enhances efficiency.

Don't rely on outdated methods—download the white paper now!

ReadCube -

Moderna, a leading mRNA technology company, saw unprecedented growth during the COVID-19 pandemic. Before this, its Medical Affairs teams aligned Research and Commercial narratives via a scientific communications platform (SCP) set annually with little change.

During the pandemic, daily data on the virus, its evolution, vulnerable populations, efficacy, durability, and real-world evidence (RWE) surged, overwhelming existing tools.

This case study explores how Moderna Medical Affairs used ReadCube’s platform as a centralized repository for efficient content management and integration, enhancing research accuracy, data efficiency, and collaboration.

Qinecsa Solutions -

🕒 Multiple time slots:

Americas: 6am | 10am | 2pm EDT

Europe: 12pm | 4pm | 8pm CET

 ⏳ Duration: 30 minutes

Sign Up Now

 What To Expect:

Join us for a focused and dynamic 30-minute session where our expert speaker dives into the latest advancements in pharmacovigilance literature screening:

✓ Gain expert insights into literature screening processes

✓ Leverage AI and automation

✓ Discover practical solutions to industry pain points

✓ Learn about emerging trends shaping the future of pharmacovigilance

✓ Q&A to address your specific questions

About The Speaker:

Dr. Preeti Verma 

✓ 20+ years in clinical practice & pharmacovigilance 

✓ Experienced in literature screening solutions 

✓ Skilled client partner 

Register Now

Can't make it? Request the recording

Synterex, Inc. -

In Part 2 of our AI & Automation series, we delve deeper into practical case studies and real-world applications of AI in medical communications. Join Synterex as we explore the next phase of AI adoption, focusing on automating business processes, optimizing medical writing workflows, and leveraging AI for better stakeholder engagement.

Watch now to learn:
How to build a business information library for efficient content generation
The role of AI-driven automation in medical writing and regulatory documentation
Best practices for explaining AI adoption to stakeholders and clients
Examples of using automation to streamline business processes

Synterex, Inc. -

Synterex partnered with MarketBeam to host "Automation & AI to Solve Business Problems in Medical Communications" in June 2024.

Discover how AI and automation are transforming medical communications in this insightful webinar hosted by Synterex. From balancing regulatory risks to optimizing business practices, this webinar delves into the practical applications of AI across the medical writing landscape.

Watch now to learn:
How AI and automation can streamline medical writing processes
Best practices for AI compliance and governance
Real-world case studies on AI’s impact on business efficiency
Key insights into managing AI-driven risks in clinical and regulatory documentation

Synterex, Inc. -

Prior to the FD&C Act, pharmaceutical companies were not required to provide proof of drug safety or a disclosure of all active ingredients. Since then, all new drugs undergo an intensive review process by the Food and Drug Administration (FDA), and ever-evolving guidance and regulations ensure that both new drugs and those with updated characteristics, such as dosing, delivery, and expanded indications, are safe and effective for the intended populations. A gap remains, however, for drug investigations including and targeted for children of varying ages.

Download and read now for more insights!

Synterex, Inc. -

Innovative development of human drugs, biologics, and medical devices (medical products) and their quick advancement through the United States Food and Drug Administration (FDA) approval pipeline is necessary to improve the lives of patients. It is also imperative for sponsors to consider diversity when enrolling study participants throughout the clinical development pipeline to adequately represent the population of patients who have a disease or condition.

Download and read now for more insights!

Berry Consultants -

This white paper will explore the business benefits and case of using the FACTS simulation software for all your clinical trial designs.

Qinecsa Solutions -

Join us for Part 2 of our webinar series on post-marketing safety surveillance, where we dive deeper into the intricate world of medical devices and drug-device combination products.

Building upon the foundation set in Part 1, this session explores the reporting essentials and obligations associated with the post-marketing safety surveillance of these products in both the EU and USA markets. Industry expert Veronika Valdova will guide you through current trends and challenges in the industry, offering valuable insights into best practices and regulatory expectations. Attendees will gain a comprehensive understanding of how to navigate the complexities of safety surveillance and ensure compliance with international standards.

Agenda:

• Introduction Drug-Device and Combination Products.
• Types of DDCs in Europe and the U.S.
• Reporting Essentials and Obligations
• Essential Procedures to Cover
• Comparison of Reporting Requirements in the EU vs the U.S.
• Current Trends and/or Challenges
• Best Practices
• Key Takeaways
• Q & A Session

For any questions about this webinar, or if you would like to request the recording, please write to: contact@qinecsa.com. Enjoy! 

Qinecsa Solutions -

Join our insightful webinar exploring the latest developments in the EU medical device vigilance landscape, with industry-renowned specialist Veronika Valdova. Learn how to seamlessly integrate medical devices into your pharma portfolio, gain practical strategies for navigating regulations, and establish robust management processes.

Key topics include: 
• Introduction to Medical Device Regulatory Requirements
• Addressing Practical Challenges
• Key Takeaways
• Q&A Session

🎯 This webinar is ideal for: 
• MedTech company leaders in acquisition by pharma
• Pharma company leaders expanding their portfolio to include device products.

For any questions about this webinar, or if you would like to request the recording, please write to: contact@qinecsa.com. Enjoy! 

Insife -

Read how Insife has created a unique service that can help pharma companies and biotechs, big and small, as well as CROs, by taking on the work of tracking changes in global regulation

Insife -

Mark your calendars for September 26th and join us at the Novartis Campus in Basel for the Insife Annual Convention - your calendars for September 26th and join us at the Novartis Campus in Basel for the Insife Annual Convention - Connect. Collaborate. Community.ect. Collaborate. Community.Mark your calendars for September 26th and join us at the Novartis Campus in Basel for the Insife Annual Convention - Connect. Collaborate. Community.

Schlafender Hase -

Intensifying regulatory requirements leave no room for error when putting goods into patients and consumers’ hands. Yet in life sciences, one of the most strictly controlled industries, more than 50% of product recalls are caused by packaging errors. 

Is your company taking all the necessary steps to ensure labeling compliance and accuracy? 

Schlafender Hase -

Accurate barcodes on healthcare packaging and labeling are just as important as any other information. An incorrect barcode can lead to expensive misprints and recalls.

When it comes to grading a digital barcode, there should never be a result other than Pass or Fail – either it is perfect or it is not.

Is your company taking all the necessary steps to ensure that your barcodes scan correctly?

Schlafender Hase -

Regulators in the life sciences industry are making clear moves to connect patients, physicians and other stakeholders across the healthcare system by implementing e-labelling initiatives. 

The goal of these initiatives is to ensure a sustainable and consistently up-to-date information source for product and safety information that isn’t dependent on paper. 

This eBook assesses the latest regulatory expectations and timelines applicable to the medical device industry. It then sets out the practical next steps manufacturers and suppliers can take now – both to prepare for compliance and to maximize the opportunities operationally and for customers.

Glemser Technologies -

In today’s rapidly evolving landscape of content management, organizations are increasingly seeking innovative approaches to streamline workflows, enhance collaboration, and meet stringent regulatory compliance. Among these transformative solutions at their disposal, the component content management system (CCMS) shines as a beacon of innovation, pushing the boundaries of traditional content management systems (CMS) by delivering a new level of efficiency, structure, and scalability.

In this blog, we delve into the realm of CCMS, exploring its unique features, its divergence from conventional content management systems, and the promising benefits it brings, particularly for regulated industries like pharmaceuticals.

Glemser Technologies -

In the fast-paced and highly regulated pharmaceutical industry, the efficient management of labeling and regulatory submissions is crucial for ensuring compliance, patient safety, and the fast and successful market entry of innovative drugs. However, this process comes with its fair share of challenges. From navigating Chemistry, Manufacturing, and Controls (CMC) regulatory requirements to addressing global labeling and clinical labeling use cases, pharmaceutical companies face complex hurdles in meeting regulatory standards while improving their speed to market. This leaves many highly regulated life science organizations to wonder – is it possible to increase speed while increasing compliance?

Insight Guide -

Given the rapid evolution of AI, dedicating a person to staying abreast of AI developments is crucial to prevent it from becoming a distraction. This article underscores the pivotal role of an AI Operations (AI Ops) specialist in driving AI transformation within associations. The AI Ops role extends beyond technical implementation, fostering a cross-departmental team to collaborate, share learnings, and promote an AI-supportive culture. Through their work, the AI Ops specialist enables associations to utilize AI effectively, showcasing measurable results and achievements and ensuring a bright AI-driven future.